Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 medications to support her weight loss goal. After six months on Wegovy ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced ...

Researchers are working to make GLP-1 medications like Ozempic and Wegovy available to consumers as pills, instead of being produced as solely inject-able treatments.

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

Race/ethnic differences appear to play a role in this heterogeneity. 1 Phenotype-based studies have suggested different subtypes of diabetes mellitus; however, given that phenotype can evolve over ...